Ohio media: Gov. DeWine orders post-release control review
UC criminal justice professor appointed by Ohio governor as part of select committee to reexamine statewide policies on post-release control supervision of felony inmates
Ed Latessa, professor of criminal justice and director of the University of Cincinnati’s School of Criminal Justice, is among nine professionals named by Ohio Gov. Mike DeWine to a working group to review statewide policies on post-release control supervision of felony inmates who have served their sentences. DeWine, who announced his Governor’s Working Group Oct. 28, said the committee will review and recommend improvements to the Ohio Adult Parole Authority’s post-release control supervision practices in Ohio. The move, the governor said, was prompted by concerns that current policies aren’t “strong enough” to monitor offender recidivism and protect the public.
Read the Ohio release here.
Read more in the Toledo Blade, Dayton 24/7 Now or WBNS in Columbus.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.